Journavx 50 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM3BP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,470
Award facts
- Contract value 100% obligated
- $10,470.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on January 26, 2026, for Journavx 50 mg tablets (30 count) with a ceiling value of $10,470.12 and an ultimate completion date of January 27, 2026. This firm fixed-price, non-set-aside contract represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 and running through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a critical vendor in the federal medical procurement supply chain, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract awards demonstrate extensive experience fulfilling competitively awarded delivery orders across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Journavx reflects the company's ongoing role in supplying pharmaceutical commodities to the Department of Defense through the DLA's Troop Support Medical contracting vehicle, which enables efficient procurement of medical products needed by military treatment facilities and related federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FM3BP?
SPE2DR26FM3BP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FM3BP worth?
The government has obligated $10,470 on SPE2DR26FM3BP.
Is contract SPE2DR26FM3BP an order under another contract?
Yes. SPE2DR26FM3BP is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3BP competed?
The extent of competition for SPE2DR26FM3BP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award